Comparison of Escherichia coli antibiotic-resistance profiles and incidence of betalactamase phenotypes in three private health facilities in Perú
Abstract
Introduction: The appearance of multidrug-resistant and beta-lactamase producing enterobacteria in outpatient care facilities represent a public health problem in Perú.
Objective: To compare the resistance profiles of uropathogenic Escherichia coli and to identify extended-spectrum beta-lactamase-producing phenotypes in three private health facilities located in the Peruvian coast, Andean and jungle regions.
Materials and methods: We conducted a descriptive study on 98 urine samples from Lima (coast), Juliaca (Andean region) and Iquitos (jungle region) during 2016. We determined the antimicrobial susceptibility in 35 samples from Lima, 38 from Juliaca and 25 from Iquitos using eight antibiotic disks in samples from patients diagnosed with urinary infection. We also evaluated the production of extended-spectrum beta-lactamases with cefotaxime and ceftazidime disks and a combination of both with clavulanic acid on Mueller-Hinton agar.
Results: We identified 18 resistance profiles ranging from those sensitive to others simultaneously resistant to seven antibiotics: 18.4% resistant to one and 54.0% to multiple antibiotics. We detected beta-lactamase production in 28.6% of the strains from the Puno region. Likewise, we observed a greater number of cases with resistance to ceftazidime, ceftriaxone, gentamicin, and trimethoprim-sulfamethoxazole in Puno’s health facility in patients within the 31 to 45 year age range.
Conclusion: Resistance profiles varied according to the geographical location of the health facilities under study. Resistance to antibiotics was higher in the Andean region with 28.6% of strains producing extended-spectrum beta-lactamases.
Downloads
References
Tony Mazzulli M. Diagnosis and management of simple and complicated urinary tract infections (UTIs). Can J Urol. 2012;19:42-8.
Bradford PA. Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-51. https://doi.org/10.1128/CMR.14.4.933-951.2001
García CS, de la Gándara MP, García FJ. Betalactamasas de espectro extendido en enterobacterias distintas de Escherichia coli y Klebsiella. Enferm Infecc Microbiol Clin. 2010;28:12-8. https://doi.org/10.1016/S0213-005X(10)70003-3
Álvarez-Almanza D. Identificación de betalactamasas de espectro extendido en enterobacterias. Revista Habanera de Ciencias Médicas. 2010;9:516-24.
Zhao W-H, Hu Z-Q. Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria. Crit Rev Microbiol. 2013;39:79-101. https://doi.org/10.3109/1040841X.2012.691460
Lu S-Y, Zhang Y-L, Geng S-N, Li T-Y, Ye Z-M, Zhang D-S, et al. High diversity of extendedspectrum beta-lactamase-producing bacteria in an urban river sediment habitat. Appl Environ Microbiol. 2010;76:5972-6. https://doi.org/10.1128/AEM.00711-10
Erb S, D’Mello-Guyett L, Malebo HM, Njee RM, Matwewe F, Ensink J, et al. High prevalence of ESBL-producing E. coli in private and shared latrines in an informal urban settlement in Dar es Salaam, Tanzania. Antimicrob Resist Infect Control. 2018;7:3. https://doi.org/10.1186/s13756-017-0292-y
Briongos‐Figuero L, Gómez‐Traveso T, Bachiller‐Luque P, Domínguez‐Gil González M, Gómez‐Nieto A, Palacios‐Martín T, et al. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended‐spectrum beta‐lactamase (ESBL)‐producing enterobacteria. I Int J Clin Pract. 2012;66:891-6. https://doi.org/10.1111/j.1742-1241.2012.02991.x
Ecker L, Olarte L, Vilchez G, Ochoa TJ, Amemiya I, Gil AI, et al. Physicians’ responsibility for antibiotic use in infants from periurban Lima, Perú. Rev Panam Salud Pública. 2011;30:574-9.
Pascual Á, López-Cerero L. Epidemiología de las BLEE en la comunidad: un problema emergente. Enferm Infecc Microbiol Clin. 2007;25(Supl.2):23-8.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Wayne: CLSI; 2011.
Galván F, Agapito J, Bravo N, Lagos J, Tamariz J. Caracterización fenotípica y molecular de Escherichia coli productoras de β-Lactamasas de espectro extendido en pacientes ambulatorios de Lima, Perú. Revista Médica Herediana. 2016;27:22-9.
Villegas MV, Blanco MG, Sifuentes-Osornio J, Rossi F. Increasing prevalence of extendedspectrum-betalactamase among Gram-negative bacilli in Latin America: 2008 update from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Braz J Infect Dis. 2011;15:34-9. https://doi.org/10.1590/S1413-86702011000100007
Arce Z, Alarcón E, Limo J, Llontop J, Valle J. Detección de genes SHV y TEM en cepas de Escherichia coli productoras de B-lactamasas de espectro extendido procedentes de dos centros hospitalarios de Chiclayo-Perú: enero-agosto 2011. Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo. 2012;5:13-6.
Rivera-Jacinto M, Rodríguez-Ulloa C, Flores-Clavo R, Serquén-López L, Arce-Gil Z. Betalactamasas de espectro extendido tipo TEM y CTX-M en Klebsiella spp. y Escherichia coli aisladas de superficies de ambientes hospitalarios. Revista Peruana de Medicina Experimental y Salud Pública. 2015;32:752-5.
Arce-Gil Z, Llontop-Núñez J, Flores-Clavo R, Fernández-Valverde D. Detección del gen CTX-M en cepas de Escherichia coli productoras de B-lactamasas de espectro extendido procedentes del Hospital Regional de Lambayeque; Chiclayo-Perú: noviembre 2012-julio 2013. Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo. 2015;6:13-6.
Yábar MN, Curi-Pesantes B, Torres CA, Calderón-Anyosa R, Riveros M, Ochoa TJ. Multirresistencia y factores asociados a la presencia de betalactamasas de espectro extendido en cepas de Escherichia coli provenientes de urocultivos. Revista Peruana de Medicina Experimental y Salud Pública. 2017;34:660-5. https://doi.org/10.17843/rpmesp.2017.344.2922
Grandez-Urbina JA, Pichardo-Rodríguez R, Corrales-Acosta E, Olortegui R, Valencia C, Pascual L, et al. Situación del mapeo microbiológico de urocultivos en un Hospital Referencial de Perú 2013-2015. Journal of the Faculty of Medicine. 2018;18:45-51. https://doi.org/10.25176/RFMH.v18.n1.1268
McKinnell JA, Stollenwerk NS, Jung CW, Miller LG. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clin Proc. 2011;86:480-8. https://doi.org/10.4065/mcp.2010.0800
Lifonzo-Mucha SJ, Tamariz-Zamudio PE, Champi-Merino RG. Sensibilidad a fosfomicina en Escherichia coli productoras de betalactamasas de espectro extendido. Revista Peruana de Medicina Experimental y Salud Pública. 2018;35:68-71. https://doi.org/10.17843/rpmesp.2018.351.3566
Some similar items:
- Azael Saldaña, José E. Calzada, Juan Garisto, Salomón Zebedes, Franklyn E. Samudio, Roberto Blandón, Óscar Avilés, Prevalence of autoantibodies against autonomic receptors in patients with chronic cardiopathies , Biomedica: Vol. 29 No. 1 (2009)
- Isabel Mayorga-Fayad, Gloria I. Lafaurie, Adolfo Contreras, Diana M. Castillo, Alexandra Barón, María del Rosario Aya, Subgingival microbiota in chronic and aggressive periodontitis in Bogotá, Colombia: an epidemiological approach , Biomedica: Vol. 27 No. 1 (2007)
- Jessika Consuegra, Sonia Jakeline Gutiérrez, Adriana Jaramillo, Ignacio Sanz, Gilberto Olave, Jorge Enrique Soto, Carlos Valencia, Adolfo Contreras, Enteric Gram negative rods and unfermented of glucose bacteria in patients with peri-implant disease , Biomedica: Vol. 31 No. 1 (2011)
- Jacqueline Chaparro, Moisés Wasserrnanz, Modification of a Radiometric Microtest to detect Plasmodium falciparum Resistance to Several Drugs , Biomedica: Vol. 19 No. 1 (1999)
- Jacqueline Chaparro, Moisés Wasserman, Comparison of in vitro technlques for the detection of Plasmodium falciparum resistance to drugs , Biomedica: Vol. 19 No. 2 (1999)
- Eliana P. Calvo, María O. Rojas, Jacqueline Chaparro, Moisés Wasserman, Expresion of the multiple drug resistance associated gene (pfMDR 1) in Colombian strains of Plasmodium falciparum , Biomedica: Vol. 19 No. 3 (1999)
- Nélida Muñoz, Clara Inés Agudelo, Maria Victoria Ovalle, María Helena Realpe, Edilma Jaramillo, Sandra Núñez, Martha Uzeta, Vianney Portilla, María del Pilar Crespo, María Elena Alvarez, Constanza Sabogal, Mercedes Cano, María Claudia Rodríguez, María Eugenia Peláez, Lesli Bruzón, Mileny Arregocés, Gloria Patricia Londoño, Gloria Inés Dussán, Liliana Patiño, Alix Robinson, Surveillance of serotypes and antimicrobial susceptibility of Salmonellaspp., Shigella spp. and Vibrio cholerae O1, 1997-1999 , Biomedica: Vol. 20 No. 3 (2000)
- Catalina de Bedout, Julio Ayabaca, Ricardo Vega, Matilde Méndez, Axel R. Santiago, María Lucrecia Pabón, Angela Tabares, Myrtha Arango, Angela Restrepo, Vance Newell, Evaluation of Candida species' susceptibility to fluconazole with the disk diffusion method. , Biomedica: Vol. 23 No. 1 (2003)
- Ernesto Montoro, Miguel Echemendía, Dihadenys Lemus, Antonio Marrero, María J. Llanes, José A. Valdivia, Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998. , Biomedica: Vol. 24 (2004): Suplemento 1
- Leidy González, Jorge Alberto Cortés, Systematic review of antimicrobial resistance in Enterobacteriaceae isolates from Colombian hospitals , Biomedica: Vol. 34 No. 2 (2014)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
